Focal nodular hyperplasia of the liver is a benign lesion that often appears incidentally on imaging performed for unrelated reasons. Most individuals remain asymptomatic, and the condition is typically discovered during routine examinations or investigations for abdominal pain.
While focal nodular hyperplasia is noncancerous and does not usually require treatment, understanding its imaging features, risk profile, and relationship with liver health is important for appropriate clinical follow-up. This overview provides a clear, practical summary for patients and clinicians.
What Is Focal Nodular Hyperplasia
| Aspect | Details | Clinical Relevance | Notes |
|---|---|---|---|
| Tissue classification | Benign liver lesion composed of normal hepatocytes, bile ducts, and fibrous tissue | Not a tumor or pre-cancerous | Strongly associated with vascular anomalies |
| Typical discovery | Found incidentally on ultrasound, CT, or MRI | Most patients have no symptoms | Lesion is usually solitary and well defined |
| Prevalence | More common in women of reproductive age | Rare in men and children | Strong link to use of combined oral contraceptives |
| Key feature on imaging | Central stellate scar with radiating septa | Contrast-enhanced patterns help differentiate from other lesions | MRI with specific sequences is often diagnostic |
Imaging Characteristics and Diagnosis
Diagnosis of focal nodular hyperplasia of liver relies primarily on cross-sectional imaging findings rather than biopsy, which helps avoid unnecessary invasive procedures. Radiologists look for characteristic patterns that distinguish this lesion from other benign or malignant masses.
Computed tomography and magnetic resonance imaging provide complementary information. On dynamic contrast-enhanced studies, the lesion typically shows early arterial enhancement with delayed isointense or slightly hyperintense appearance relative to liver parenchyma in the portal venous phase. The central scar may enhance in a delayed manner.
Magnetic resonance imaging with hepatobiliary contrast agents adds further diagnostic confidence. During the hepatobiliary phase, focal nodular hyperplasia often demonstrates iso- or slight hyperintensity due to retained function of the benign hepatocytes. These imaging features frequently allow noninvasive diagnosis without the need for tissue sampling.
Clinical Management and Follow-up
Most patients with focal nodular hyperplasia do not require intervention, and management focuses on confirming the diagnosis, addressing symptoms, and clarifying any imaging uncertainty. Regular follow-up is reserved for select cases, while others may be discharged after appropriate imaging review.
Indications for further evaluation or treatment include persistent abdominal pain attributable to the lesion, lesion growth over time, diagnostic ambiguity, or patient anxiety that affects quality of life. In such situations, a multidisciplinary team including hepatology, radiology, and surgery can guide the safest approach.
Risk Factors and Associations
Understanding the risk profile of focal nodular hyperplasia helps clinicians and patients contextualize its benign nature and low impact on long-term liver health. The lesion has a strong demographic and pharmacologic association profile that guides initial assessment.
Key associations include female sex, use of combined hormonal contraceptives, and anabolic steroid exposure. Most patients present between the third and fifth decades of life. Incidence appears to be rising, likely due to increased use of abdominal imaging and widespread oral contraceptive use.
Key Takeaways and Practical Recommendations
- Focal nodular hyperplasia is a common benign liver lesion frequently identified on imaging.
- It is strongly associated with female gender, reproductive age, and use of combined hormonal contraceptives.
- Diagnosis is usually based on characteristic MRI or CT findings, especially the central scar and arterial enhancement pattern.
- Biopsy is generally avoided due to the low risk of bleeding and the typical radiologic appearance.
- Asymptomatic patients with typical imaging features often require no treatment beyond reassurance and periodic imaging when indicated.
- Symptomatic cases or those with indeterminate features should be evaluated by a multidisciplinary liver team.
- Long-term outcomes are excellent, and the lesion does not increase the risk of liver cancer.
FAQ
Reader questions
Can focal nodular hyperplasia of the liver turn into cancer?
No, focal nodular hyperplasia is a benign lesion and does not transform into liver cancer.
Do I need surgery if I have focal nodular hyperplasia?
Surgery is rarely needed; it is usually reserved for symptomatic cases or diagnostic uncertainty.
Will stopping hormonal contraceptives make the lesion disappear?
Regression after discontinuation of contraceptives is uncommon, but further growth is unlikely without ongoing exposure.
Is follow-up imaging necessary for focal nodular hyperplasia?
Routine follow-up imaging is not required for typical lesions confirmed with characteristic imaging features.